Meprobamate 62332-0020-31
- Manufacturer
- Alembic Pharmaceuticals Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIV
- Marketing Start
- March 31, 2016
- Listing Expires
- December 31, 2026
- Application
- ANDA090122
Active Ingredients
| Ingredient | Strength |
|---|---|
| Meprobamate | 400 mg/1 |
Selected Package
62332-0020-31Selected100 TABLET in 1 BOTTLE (62332-020-31)
Other packages for this product(2)
30 TABLET in 1 BOTTLE (62332-020-30)
1000 TABLET in 1 BOTTLE (62332-020-91)